Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jenscare Scientific CoHKSE:09877 +0.60%33 PB Ratio is 3.58 as of Aug. 18, 2026, which is 9% below its 10-year median of 3.92. GuruFocus rates HKSE:09877 with a GF Score™ of 33/100. The stock has 4 warning signs investors should review. Among 782 Medical Devices & Instruments companies, Jenscare Scientific Co ranks worse than 69.44% on this metric.
Jenscare Scientific Co Ltd stock PB Ratio (=3.58) is close to 1-year low of 3.24.
The historical rank and industry rank for Jenscare Scientific Co's PB Ratio or its related term are showing as below:
HKSE:09877'
s PB Ratio Range Over the Past 10 Years
Min: 3.24 Med: 3.92 Max: 4.72
Current: 3.58
During the past 6 years, Jenscare Scientific Co's highest PB Ratio was 4.72. The lowest was 3.24. And the median was 3.92.
HKSE:09877's PB Ratio is ranked worse than 69.44% of 782
companies
in the Medical Devices & Instruments industry
Industry Median: 2.125
vs HKSE:09877: 3.58
During the past 12 months, Jenscare Scientific Co's average Book Value Per Share Growth Rate was -12.40% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -17.20% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 6.40% per year.
During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of Jenscare Scientific Co was 47.80% per year. The lowest was -17.20% per year. And the median was -14.30% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Jenscare Scientific Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jenscare Scientific Co PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Jenscare Scientific Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Jenscare Scientific Co's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Jenscare Scientific Co (HKSE:09877) has a PB Ratio of 3.58 as of Aug. 18, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Jenscare Scientific Co and its competitors. This is near median its historical median of 3.92. Over the past decade, Jenscare Scientific Co's PB Ratio has ranged from 3.24 to 4.72. According to the industry distribution chart, Jenscare Scientific Co ranks #543 out of 782 companies in the Medical Devices & Instruments industry, placing it in the top 69.4%.
Is Jenscare Scientific Co's PB Ratio too high?
Jenscare Scientific Co's current PB Ratio of 3.58 is near median its 10-year median of 3.92. Over the past 10 years, this metric has ranged from a low of 3.24 to a high of 4.72. The Medical Devices & Instruments industry median PB Ratio is 2.13. Jenscare Scientific Co's value of 3.58 is 68.5% above this industry median. Based on the distribution chart, Jenscare Scientific Co ranks #543 out of 782 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Jenscare Scientific Co has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Jenscare Scientific Co's PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Jenscare Scientific Co ranks #543 out of 782 companies for PB Ratio. This places Jenscare Scientific Co in the lower half of its industry. The industry median PB Ratio is 2.13. Jenscare Scientific Co's value of 3.58 is 68.5% above this benchmark. Historically, Jenscare Scientific Co's own PB Ratio has ranged from 3.24 to 4.72 over the past decade. While the company's 10-year median is 3.92 vs. the industry median of 2.13, Jenscare Scientific Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.13, based on 782 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jenscare Scientific Co's current PB Ratio of 3.58 is 68.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Jenscare Scientific Co and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jenscare Scientific Co's current PB Ratio is 3.58, which is near median its own 10-year median of 3.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jenscare Scientific Co stock overvalued right now?
Jenscare Scientific Co (HKSE:09877) has a current PB Ratio of 3.58. The current PB Ratio is 3.58, which is near median its 10-year median of 3.92 and 68.5% above the Medical Devices & Instruments industry median of 2.13. Jenscare Scientific Co's overall GF Score™ is 33/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Jenscare Scientific Co (HKSE:09877), the current PB Ratio is 3.58 as of Aug. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Jenscare Scientific Co Ltd is engaged in the manufacturing, research, and development of medical devices. The company develops interventional products for the treatment of structural heart disease. The company's core products include LuX-Valve and Ken-Valve. LuX-Valve is a transcatheter tricuspid valve replacement system designed for patients with severe tricuspid regurgitation and high surgical risk. Ken-Valve is designed for the treatment of severe aortic regurgitation or combined with aortic stenosis. The company also develops product candidates for the treatment of mitral valve diseases and medical devices for the treatment of heart failure. Geographically, the company generates the majority of its revenue from the Chinese mainland.
33GF Score
Get the complete analysis for HKSE:09877
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:09877 has been successfully added to your 
